Tuberous Sclerosis Complex - Diagnosis and Management

85.6K

views

314

authors

16

articles

Editorial

05 October 2021

Editorial: Tuberous Sclerosis Complex – Diagnosis and Management

Sergiusz Jozwiak

and

Paolo Curatolo

2,744 views

2 citations

Editors

2

Sergiusz Jozwiak

Children's Memorial Health Institute (IPCZD)

University of Rome Tor Vergata

Impact

About

There is common agreement that there are still gaps in understanding the course of Tuberous Sclerosis Complex (TSC) manifestations and their prognostic role, rare symptoms and co-morbidities, interventions, treatments, and their outcomes, and Quality of Life (QoL). TuberOus SClerosis registry to increAse disease awareness (TOSCA), this largest multicentered, multinational registry of the 2211 TSC patients enrolled from 31 countries worldwide, was designed to address many of these gaps by collecting data from patients across many countries worldwide.

The results of TOSCA will assist in filling the gaps in understanding the natural history of TSC and will help in planning better management and surveillance strategies. Comprehensive surveillance will lead to more pro-active and pre-emptive treatment and better outcomes in future. The data collected might inform patient's treatment standards and promote research in TSC.

The Research Topic will include papers reporting results of this TOSCA analysis, but also welcomes other manuscripts covering TSC.

We acknowledge the funding of some of the manuscripts submitted to this Research Topic by the company Novartis Oncology. We hereby state publicly that Novartis Oncology has had no editorial input in articles included in this Research Topic, thus ensuring that all aspects of this Research Topic are evaluated objectively, unbiased by any specific policy or opinion of Novartis Oncology

There is common agreement that there are still gaps in understanding the course of Tuberous Sclerosis Complex (TSC) manifestations and their prognostic role, rare symptoms and co-morbidities, interventions, treatments, and their outcomes, and Quality of Life (QoL). TuberOus SClerosis registry to increAse disease awareness (TOSCA), this largest multicentered, multinational registry of the 2211 TSC patients enrolled from 31 countries worldwide, was designed to address many of these gaps by collecting data from patients across many countries worldwide.

The results of TOSCA will assist in filling the gaps in understanding the natural history of TSC and will help in planning better management and surveillance strategies. Comprehensive surveillance will lead to more pro-active and pre-emptive treatment and better outcomes in future. The data collected might inform patient's treatment standards and promote research in TSC.

The Research Topic will include papers reporting results of this TOSCA analysis, but also welcomes other manuscripts covering TSC.

We acknowledge the funding of some of the manuscripts submitted to this Research Topic by the company Novartis Oncology. We hereby state publicly that Novartis Oncology has had no editorial input in articles included in this Research Topic, thus ensuring that all aspects of this Research Topic are evaluated objectively, unbiased by any specific policy or opinion of Novartis Oncology

Download ebook

Share

Editors

Sergiusz Jozwiak

Children's Memorial Health Institute (IPCZD)

University of Rome Tor Vergata

Impact

85,601 Total views

62,379 Article views

21,727 Article downloads

1,495 Topic views

Published In

Journal Thumbnail

Frontiers in Neurology

Pediatric Neurology

Journal Thumbnail

Frontiers in Pediatrics

Pediatric Neurology

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic